Skip to main content
Department of Pharmaceutics

Research Our research plan for the next 5 years (2019-2023):

Main research activities

Several active research groups in the department are engaged with different aspects of pharmaceutics. The research is directed towards high quality innovative topics aiming to publish applied articles.

The research plan in the period from 2019 till 2023 is still focusing on three distinct areas:

  1. Nanotechnology as a promising area of pharmaceutical science is a target for formulation of many drugs.
  2. Preformulation studies to improve the characteristics of drugs and/or dosage forms and development of more acceptable dosage forms.
  3. Targeted drug delivery systems 
# Title Research Year
131 Self-Emulsifying Drug-Delivery Systems Modulate P-Glycoprotein Activity: Role of Excipients and Formulation Aspects 2018
132 Enhancing Docetaxel Delivery to Multidrug-Resistant Cancer Cells with Albumin-Coated Nanocrystals 2018
133 Mucoadhesive Tablets for the Vaginal Delivery of Progesterone: In Vitro Evaluation and Pharmacokinetics/Pharmacodynamics in Female Rabbits 2018
134 Fluorouracil-Loaded Gold Nanoparticles for the Treatment of Skin Cancer : Development, in Vitro Characterization, and in Vivo Evaluation in a Mouse Skin Cancer Xenograft Model 2018
135 Nanostructured Lipid Carriers for Improved Oral Delivery and Prolonged Antihyperlipidemic Effect of Simvastatin 2018
136 Lipid-Coated Superparamagnetic Nanoparticles for Thermoresponsive Cancer Treatment 2018
137 Novel Targeted Lipid Nanoparticles Loaded with Synergistic Chemotherapy- Gene therapy Combination for Effective Treatment of Hepatocellular Carcinoma 2018
138 Mucoadhesive Tablets for the Vaginal Delivery of Progesterone: In Vitro Evaluation and Pharmacokinetics/Pharmacodynamics in Female Rabbits 2018
139 Fluorouracil-Loaded Gold Nanoparticles for the Treatment of Skin Cancer : Development, in Vitro Characterization, and in Vivo Evaluation in a Mouse Skin Cancer Xenograft Model 2018
140 Nanostructured Lipid Carriers for Improved Oral Delivery and Prolonged Antihyperlipidemic Effect of Simvastatin 2018